MARKET

NAVB

NAVB

Navidea Biopharm
EXMKT
0.0001
NaN%
Closed 09:30 06/14 EDT
OPEN
--
PREV CLOSE
0.0001
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.350
52 WEEK LOW
0.0001
MARKET CAP
10.01K
P/E (TTM)
-0.0018
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at NAVB last week (0603-0607)?
Weekly Report · 6d ago
Weekly Report: what happened at NAVB last week (0527-0531)?
Weekly Report · 06/03 11:12
Weekly Report: what happened at NAVB last week (0520-0524)?
Weekly Report · 05/27 11:16
Weekly Report: what happened at NAVB last week (0513-0517)?
Weekly Report · 05/20 11:10
Weekly Report: what happened at NAVB last week (0506-0510)?
Weekly Report · 05/13 11:20
Weekly Report: what happened at NAVB last week (0429-0503)?
Weekly Report · 05/06 11:27
Weekly Report: what happened at NAVB last week (0422-0426)?
Weekly Report · 04/29 11:35
Weekly Report: what happened at NAVB last week (0415-0419)?
Weekly Report · 04/22 11:22
More
About NAVB
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It is developing multiple precision-targeted products based on its Manocept platform to enhance patient care by identifying the sites and pathways of undetected disease. The Company’s business is focused on two primary types of drug products, such as diagnostic substances, including Tc99m tilmanocept and other diagnostic applications of its Manocept platform, and therapeutic development programs, including therapeutic applications of its Manocept platform. It has developed processes for producing the first four therapeutic Manocept immuno-construct series, the Manocept doxorubicin (MAN-DOX) series, which is designed to specifically target and kill or modify activated CD206+ macrophages by delivering doxorubicin, a Manocept paclitaxel series (MAN-PAC), and a Manocept Bisphosphonate series (MAN-BIS).

Webull offers Navidea Biopharmaceuticals Inc stock information, including EXMKT: NAVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAVB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NAVB stock methods without spending real money on the virtual paper trading platform.